Skip to main content

Unfortunately we don't fully support your browser. If you have the option to, please upgrade to a newer version or use Mozilla Firefox, Microsoft Edge, Google Chrome, or Safari 14 or newer. If you are unable to, and need support, please send us your feedback.

Elsevier
Publish with us
Press release

Elsevier secures publishing rights for premium titles for 2023

Amsterdam | November 14, 2022

Titles from six prominent medical societies to be added to publisher’s direct subscription portfolio

Elsevier, a leading scientific publisher, and global information analytics business specializing in science and health, announced today that it will be the new publisher of six influential society journals starting in January 2023:

  • American Journal of Clinical Nutrition

  • The Journal of Nutrition

  • Journal of Thrombosis and Haemostasis

  • American Journal of Transplantation

  • Laboratory Investigation

  • Modern Pathology

The newly acquired titles represent the following societies and add to Elsevier’s expansive global health publishing portfolio:

  • American Society for Nutrition (ASN)

  • United States and Canadian Academy of Pathology (USCAP)

  • International Society on Thrombosis and Haemostasis (ISTH)

  • The American Society of Transplant Surgeons (ASTS)

  • American Society of Transplantation (AST)

All are considered internationally renowned sources of knowledge and impactful study in the fields of pathology, nutrition, transplantation, haematology and peripheral vascular disease.

“It is an honor to partner with five established societies that have trusted Elsevier as the official publisher of their important journals. True to our commitment to supporting research and clinical practice, we are dedicated to placing our full range of industry-leading resources for authors, editors, reviewers and readers, in the disposal of our latest additions. With our continuous support and seamless collaboration these six valued titles can harness the benefits of a reliable global publishing partner allowing them to maximize their contribution to scientific research and clinical practice in their respective fields” said Carl Schwarz Senior Vice President, Health and Medical Sciences, at Elsevier. Elsevier will officially welcome the journals into their portfolio beginning in January 2023. They will be part of Elsevier’s title-by-title subscription model instead of a collection.

Learn more about these exceptional titles or contact us for more information.

About Elsevier

As a global leader in scientific information and analytics, Elsevier helps researchers and healthcare professionals advance science and improve health outcomes for the benefit of society. We do this by facilitating insights and critical decision-making with innovative solutions based on trusted, evidence-based content and advanced AI-enabled digital technologies.

We have supported the work of our research and healthcare communities for more than 140 years. Our 9,500 employees around the world, including 2,500 technologists, are dedicated to supporting researchers, librarians, academic leaders, funders, governments, R&D-intensive companies, doctors, nurses, future healthcare professionals and educators in their critical work. Our 2,900 scientific journals and iconic reference books include the foremost titles in their fields, including Cell Press, The Lancet and Gray’s Anatomy.

Together with the Elsevier Foundation(opens in new tab/window), we work in partnership with the communities we serve to advance inclusion and diversity in science, research and healthcare in developing countries and around the world.

Elsevier is part of RELX(opens in new tab/window), a global provider of information-based analytics and decision tools for professional and business customers. For more information on our work, digital solutions and content, visit www.elsevier.com.

Contact

Headshot of Dan DiPietro-James

DD

Dan DiPietro-James

Global Media Relations Director

Elsevier

+1 773-251-8744

E-mail Dan DiPietro-James